Levodopa in Mucuna pruriens and its degradation

被引:48
作者
Pulikkalpura, Haridas [1 ]
Kurup, Rajani [2 ]
Mathew, Paravanparampil Jacob [1 ]
Baby, Sabulal [2 ]
机构
[1] Jawaharlal Nehru Trop Bot Garden & Res Inst, Plant Genet Resource Div, Thiruvananthapuram 695562, Kerala, India
[2] Jawaharlal Nehru Trop Bot Garden & Res Inst, Phytochem & Phytopharmacol Div, Thiruvananthapuram 695562, Kerala, India
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
关键词
L-DOPA; QUANTITATIVE-DETERMINATION; PARKINSONS-DISEASE; SEEDS; GERMPLASM; DISAGGREGATION; NEUROTOXICITY; QUALITY; STRESS; LEGUME;
D O I
10.1038/srep11078
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mucuna pruriens is the best known natural source of L-dopa, the gold standard for treatment of Parkinsonism. M. pruriens varieties are protein rich supplements, and are used as food and fodder worldwide. Here, we report L-dopa contents in seeds of fifty six accessions of four M. pruriens varieties, M. pruriens var. pruriens, M. pruriens var. hirsuta, M. pruriens var. utilis and M. pruriens var. thekkadiensis, quantified by HPTLC-densitometry. L-dopa contents varied between 0.58 to 6.42 (%, dr. wt.). High and low L-dopa yielding genotypes/chemotypes of M. pruriens could be multiplied for medicinal and nutritional purposes, respectively. HPTLC profiles of M. pruriens seeds on repeated extraction (24 h) in 1:1 formic acid-alcohol followed by development in butanol: acetic acid: water (4:1:1, v/v) showed consistent degradation of L-dopa (Rf 0.34 +/- 0.02) into a second peak (Rf 0.41 +/- 0.02). An average of 52.11% degradation of L-dopa was found in seeds of M. pruriens varieties. Since M. pruriens seeds and/or L-dopa are used for treatment of Parkinson's disease and as an aphrodisiac both in modern and/or traditional systems of medicine, the finding of high level of L-dopa degradation (in pure form and in M. pruriens extracts) into damaging quinones and ROS is very significant.
引用
收藏
页数:9
相关论文
共 49 条
[1]   Levodopa: the story so far [J].
Abbott, Alison .
NATURE, 2010, 466 (7310) :S6-S7
[2]  
[Anonymous], 1995, J Altern Complement Med, V1, P249
[3]   Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease [J].
Asanuma, M ;
Miyazaki, I ;
Ogawa, N .
NEUROTOXICITY RESEARCH, 2003, 5 (03) :165-176
[4]  
BASMA AN, 1995, J NEUROCHEM, V64, P825
[5]   Complementary & Alternative Management of Parkinson's Disease: An Evidence-Based Review of Eastern Influenced Practices [J].
Bega, Danny ;
Zadikoff, Cindy .
JOURNAL OF MOVEMENT DISORDERS, 2014, 7 (02) :57-66
[6]   Development and Validation of an HPTLC - Densitometric Method for Determination of Levodopa in seeds of Mucuna pruriens and its capsule dosage form [J].
Behera, Anindita ;
Sankar, Dannana G. ;
Si, Sudam C. .
EURASIAN JOURNAL OF ANALYTICAL CHEMISTRY, 2010, 5 (02) :126-136
[7]   L-DOPA AND PARKINSONISM [J].
CALNE, DB ;
SANDLER, M .
NATURE, 1970, 226 (5240) :21-+
[8]   Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons [J].
Cheng, NN ;
Maeda, T ;
Kume, T ;
Kaneko, S ;
Kochiyama, H ;
Akaike, A ;
Goshima, Y ;
Misu, Y .
BRAIN RESEARCH, 1996, 743 (1-2) :278-283
[9]   Oxidative metabolism of dopamine: A colour reaction from human midbrain analysed by mass spectrometry [J].
De Iuliis, Angela ;
Arrigoni, Giorgio ;
Andersson, Liselotte ;
Zambenedetti, Pamela ;
Burlina, Alessandro ;
James, Peter ;
Arslan, Paola ;
Vianello, Fabio .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (11) :1687-1693
[10]  
Dethy S, 1997, CLIN CHEM, V43, P740